L

Ligand Pharmaceuticals
D

LGND

115.690
USD
-1.68
(-1.43%)
مغلق
حجم التداول
0
الربح لكل سهم
6
العائد الربحي
-
P/E
46
حجم السوق
2,186,005,702
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    A
    AGIO
    0.790
    (2.37%)
    34.060 USD
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    J
    JAZZ
    -0.625
    (-0.51%)
    120.820 USD
    N
    NBIX
    0.840
    (0.58%)
    146.750 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.